https://en.wikipedia.org/wiki/Surgisphere
Surgisphere and Desai also published a problematic paper which suggested ivermectin reduced COVID-19 mortality.[9] It was a retrospective matched-control study of coronavirus patients using a "real-time hospitalization database" published preprint in April 2020, but withdrawn as of May 2020.[25][22]
Surgisphere promoted a "rapid diagnostic tool" for COVID-19, stating it was in use by over 1000 hospitals.[26][27]
Company credibility
A parallel investigation by the British daily The Guardian revealed that several of Surgisphere's employees had little or no data or scientific background; one employee appeared to be a science fiction author while another, listed as a marketing executive, was an adult model and events hostess. The Guardian also found that Surgisphere's LinkedIn page has fewer than 100 followers and in late May 2020 listed only six employees. It also found that the company had almost no online presence and that its Twitter account had made no posts from October 2017 to March 2020.[8]
An investigation of one of Desai's early first author papers[28] has found apparent evidence of image manipulation.[29]
Desai also attempted to launch a neurofeedback device on Indiegogo in 2012.[30][8]
选择“Disable on www.wenxuecity.com”
选择“don't run on pages on this domain”
